AVTR Jan 2024 30.000 put
| Previous close | 8.94 |
| Open | 8.94 |
| Bid | 7.00 |
| Ask | 10.60 |
| Strike | 30.00 |
| Expiry date | 2024-01-19 |
| Day's range | 8.94 - 8.94 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
ZacksAvantor's (AVTR) New Tie-Up to Improve Lab Inventory Management
Avantor's (AVTR) latest partnership is expected to significantly optimize labs' inventory management and the overall workflow.
ZacksAvantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
Despite Avantor's (AVTR) strength in bioproduction and strength in Applied Technologies and Advanced Materials end markets, it reports an overall soft Q1 performance.
ZacksAvantor, Inc. (AVTR) Q1 Earnings and Revenues Beat Estimates
Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 3.57% and 0.85%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksAnalysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for
Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksHere's Why You Should Retain Avantor (AVTR) Stock for Now
Investors continue to be optimistic about Avantor's (AVTR) strong product portfolio.
MediaOutReachAvantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards
Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumablesSINGAPORE - ACN Newswire - 16 March 2023 - Avantor, a leading global provider of mission-critical products and services to customers in the life sciences, education, government and advanced technologies & applied materials industries, has been accorded the Best Bioprocessing Company for Chromatography at the Asia-Pacific Bioprocessing Excellence Awards 2023 (ABEA). Narayana Ra
ZacksCentene (CNC) Q4 Earnings Miss on High Costs, '23 Premium View Up
Centene's (CNC) fourth-quarter results suffer from elevated medical expenses, partly offset by growing premium and service revenues.
ZacksAvantor (AVTR) Q4 Earnings Surpass Estimates, Margins Up
Despite Avantor's (AVTR) robust core organic sales across its segments, it reports an overall soft Q4 performance.
ZacksAvantor, Inc. (AVTR) Q4 Earnings and Revenues Top Estimates
Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 6.67% and 0.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ZacksPremier, Inc. (PINC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Premier, Inc. (PINC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksViatris (VTRS) Down 1.5% Since Last Earnings Report: Can It Rebound?
Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Avantor (AVTR) Q3 Earnings Top Estimates, 2022 EPS View Cut
Avantor's (AVTR) robust performance across the majority of its segments drives its Q3 sales, despite business challenges.
ZacksAvantor, Inc. (AVTR) Q3 Earnings and Revenues Top Estimates
Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 3.03% and 0.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ZacksEarnings Preview: Avantor, Inc. (AVTR) Q3 Earnings Expected to Decline
Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksAre Options Traders Betting on a Big Move in Avantor (AVTR) Stock?
Investors need to pay close attention to Avantor (AVTR) stock based on the movements in the options market lately.
ZacksU.S. Market Faces Worst Meltdown Since 2020: Here's Why
Major U.S. indices nosedived on Sep 14 following the inflation report for the month of August.
- Zacks
Implied Volatility Surging for Avantor (AVTR) Stock Options
Investors need to pay close attention to Avantor (AVTR) stock based on the movements in the options market lately.
MediaOutReachAvantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore
Avantor Foundation grants to healthcare charitable organizations - HealthServe and SATA CommHealth - will aid more than 1,000 beneficiariesSINGAPORE - ACN Newswire - 24 August 2022 - Avantor Foundation, Avantor's philanthropic arm, committed financial resources to healthcare charitable organizations, HealthServe and SATA CommHealth, as part of the Foundation's mission to provide healthcare to those in need. The grants will offer much-needed support to communities who would otherwise be unable to
- Zacks
Avantor's (AVTR) Stock Falls 8.8% Since Q2 Earnings Miss
Avantor's (AVTR) robust performance across majority of its segments drives its Q2 sales, despite business challenges.
- Motley Fool
Why Avantor Stock Crashed 10% Today
Shares of chemical reagents producer Avantor (NYSE: AVTR) are slumping today, down by 10.4% as of 2 p.m. ET, after the company posted a bit of a miss in its Q2 earnings report last night. Expected to earn $0.38 per share on sales of $2 billion, Avantor instead reported a profit of $0.37 per share and sales closer to $1.9 billion. The bad news is that the $0.37 per share that Avantor earned in its fiscal second quarter 2022 was only a pro forma number.
ZacksAvantor, Inc. (AVTR) Lags Q2 Earnings and Revenue Estimates
Avantor, Inc. (AVTR) delivered earnings and revenue surprises of -2.63% and 3.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
AVTR or DOCS: Which Is the Better Value Stock Right Now?
AVTR vs. DOCS: Which Stock Is the Better Value Option?
ZacksFactors that Make Acadia Healthcare (ACHC) an Attractive Bet Now
Solid demand for behavioral healthcare services, growth-related efforts in the form of JVs, declining debt burden and sufficient cash-generating abilities continue to benefit Acadia Healthcare (ACHC).
ZacksAVTR vs. DOCS: Which Stock Is the Better Value Option?
AVTR vs. DOCS: Which Stock Is the Better Value Option?
ZacksThe Beauty Health Company (SKIN) Stock Jumps 5.6%: Will It Continue to Soar?
The Beauty Health Company (SKIN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.